Skip to main content

Topic

Claim Construction

303 published works

  1. PTAB Litigation Blog

    Claim Construction Stipulation Avoids Discretionary Denial

    By Matthew Johnson

    Visit Jones Day's PTAB Litigation blog at www.ptablitigationblog.com. By Ian Adams, Matt Modderman, Matt Johnson – USPTO Director John Squires issued a decision on October 3, 2025, denying a request…

  2. Intellectual Property Law Blog

    Deletions Matter: The Federal Circuit Rejects Importing Language from Provisional and Related Patent into FMC’s Asserted Claims

    By Joshua Weisenfeld

    This case addresses two primary issues (i) whether the district court erred in construing the claim term “composition” in FMC’s pesticide patents to mean only “stable compositions,” based on disclosures…

  3. Intellectual Property Law Blog

    Claim Construction: Indefinite or Clerical Error?

    By Sunny Akarapu

    This Federal Circuit opinion analyzes the “very demanding standard” of judicial correction of erroneous wording of a patent claim. Background Canatex Completion Solutions owns U.S. Patent No. 10,794,122. This patent…

  4. IP IQ

    When Courts Can Fix Patent Claim Errors: Federal Circuit Reverses Indefiniteness Ruling in Oil and Gas Equipment Case

    By Stephanie D. Scruggs

    The Federal Circuit’s recent decision in Canatex Completion Solutions, Inc. v. Wellmatics, LLC is a good example of the courts’ ability to correct obvious errors in patent claims through claim…

  5. PTAB Litigation Blog

    Divergent Claim Construction Results in Discretionary Denial

    By Matthew Johnson

    Visit Jones Day's PTAB Litigation blog at www.ptablitigationblog.com. By Evan Tassis and Matt Johnson – In a recent decision, Acting Director Coke Morgan Stewart granted Patent Owner’s request for discretionary…

  6. Intellectual Property Law Blog

    Lexicography: Clear And Unequivocal

    By Sunny Akarapu

    This Federal Circuit opinion analyzes lexicography in the context of claim construction. Background Alnylam Pharmaceuticals owns U.S. Patent Nos. 11,246,933 (parent) and 11,382,979 (child). These patents relate to biodegradable lipids and…

  7. Intellectual Property Law Blog

    Federal Circuit Vacates Summary Judgement: Limitations from Specifications Should Not Have Been Imported Into the Claims

    By Holly Zhang

    The Federal Circuit vacated and remanded the district court’s summary judgement of noninfringement, finding that the lower court had improperly construed the claim term “pull cord.” The district court had erroneously…

  8. PTAB Law Blog

    Understanding the PTAB’s Recent Informative Decision: Cambridge Mobile Telematics, Inc. v. Sfara, Inc.

    By James Pawlowski

    The Patent Trial and Appeal Board (PTAB) recently designated its decision in Cambridge v. Sfara (IPR2024-00952) as an informative decision.[1] This designation addresses an important issue in inter partes review…

  9. Intellectual Property Law Blog

    Federal Circuit Highlights the Importance of Separating Claim Construction and Infringement Analysis When Dealing with After-Arising Technology

    By Brandon Buck

    Novartis Pharmaceuticals Corporation v. Torrent Pharma Inc., No. 23-2218 (Fed. Cir. 2025) — On January 10, 2025, the Federal Circuit reversed the district court’s opinion that claims of a Novartis…

  10. PTABWatch

    No Words, No Waiver: No Obligation to Request Rehearing to Preserve Issue for Appeal

    By Marshall Gerstein

    In Voice Tech Corp v. Unified Patents, LLC, the Federal Circuit affirmed the PTAB’s IPR decision that the challenged claims of Voice Tech’s patent were unpatentable for obviousness, determining that…